← Back

Wire · opportunities

FDA Clears CCTA-Based AI Software for Facilitating Management of Coronary Artery Disease

Published

19 November 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at diagnosticimaging.com →

◆ Verified

Fusion42 · 19 November 2026 · Fusion42 review

The FDA granted 510(k) clearance to Syngo.CT Coronary Cockpit, an AI software by Siemens Healthineers that automates analysis of coronary plaque from CCTA scans and supports planning of coronary interventions.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You can now build clinical workflows incorporating FDA-cleared AI for coronary plaque analysis, creating new diagnostic tools and intervention planning aids in cardiology imaging.

◆ Coverage

1 source · 19 Nov 2026

◆ Related on Wire

◆ Topics

MedtechFDA-clearanceAI-softwarecoronary-artery-diseasemedical-imagingCCTA